Medical Condition

aortic valve stenosis

Total Trials

16

Recruiting Now

16

Trial Phases

Various

ClinicalMetric tracks all active clinical trials for aortic valve stenosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — aortic valve stenosis Clinical Trials

How many clinical trials are currently recruiting for aortic valve stenosis?

ClinicalMetric currently tracks 16 actively recruiting clinical trials for aortic valve stenosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 16. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for aortic valve stenosis?

aortic valve stenosis research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a aortic valve stenosis clinical trial?

Eligibility criteria for aortic valve stenosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Top Sponsors

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval 2 trials

Henrik Wiggers 1 trial

National Research Center for Cardiac Surgery, Kazakhstan 1 trial

Montreal Heart Institute 1 trial

Shanghai MicroPort CardioFlow Medtech Co., Ltd. 1 trial

aortic valve stenosis

Frequently Asked Questions — aortic valve stenosis Clinical Trials

Recruiting Clinical Trials

Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis

Transcatheter Aortic Valve Implantation Registry at the National Research Center for Cardiac Surgery, Nur-Sultan, Kazakhstan

Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI

VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

Ischemic And Bleeding Risk Assessment After TAVR

Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.

REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

The Leipzig TAVI Registry

European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study

A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease

Preoperative CT-imaging with Patient-specific Computer Simulation in Transcatheter Aortic Valve Replacement

A Study to Obtain Imaging Data in 40 Patients Having Transcatheter Aortic Valve Implantation (TAVI)

Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR

Remote Cardiovascular Monitoring in Post-TAVI Patients

Hamburg AoRtic Valve cOhoRt

Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions